Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Jun 2019 for PROGENICS PHARMACEUTICALS INC, €188k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Peter J. Crowley: trading record in brief
Peter J. Crowley discloses dealings in Progenics Pharmaceuticals Inc to SEC (Form 4). Activity is concentrated on a single trading day, 26 June 2019, with 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 27 June 2019: an option exercise of €188k, in Progenics Pharmaceuticals Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Peter J. Crowley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
40,000 shares@ US$5.3580.1% of flowCommon StockSEC:0001562180-19-003659:1
10,000 shares@ US$5.3319.9% of flowCommon StockSEC:0001562180-19-003659:0
2 of 2 declarations
